Browse by People

Collapse authors list.
Back, David, Belperio, Pamela, Bondin, Mark, Negro, Francesco, Talal, Andrew H, Park, Caroline, Zhang, ZhenZhen, Pinsky, Brett, Crown, Eric, Mensa, Federico J et al (show 1 more authors) and Marra, Fiona ORCID: 0000-0003-1326-1149 (2019) Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis. JOURNAL OF VIRAL HEPATITIS, 26 (8). pp. 951-960.

Bourgeois, Stefan, Curescu, Manuela G, Larrey, Dominique G, Marra, Fiona ORCID: 0000-0003-1326-1149, Dorr, Patrick, Charafeddine, Mariem, Crown, Eric, Bondin, Mark and Back, David J (2017) Impact of Comorbidities and Comedications on the Effectiveness of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin in Clinical Practice: Real-World Evidence From a Multicountry Postmarketing Observational Study. .

Collapse authors list.
Larrey, Dominique, Puoti, Massimo, Piekarska, Anna, Back, David, Marra, Fiona ORCID: 0000-0003-1326-1149, Bondin, Mark, Raheja, Ritu, Zhang, Zhenzhen, Kalluri, Hari V, Marcinak, John et al (show 1 more authors) and Roncero, Carlos (2020) POLYPHARMACY IN HCV-INFECTED PATIENTS WHO USE DRUGS TREATED WITH GLECAPREVIR/PIBRENTASVIR: A REAL-WORLD ANALYSIS FROM 9 COUNTRIES. .

Collapse authors list.
Lampertico, Pietro, Mauss, Stefan, Persico, Marcello, Barclay, Stephen T, Marx, Steven, Lohmann, Kristina, Bondin, Mark, Zhang, ZhenZhen, Marra, Fiona ORCID: 0000-0003-1326-1149, Belperio, Pamela S et al (show 2 more authors) , Wedemeyer, Heiner and Flamm, Steven (2020) Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naive Patients with Compensated Cirrhosis. ADVANCES IN THERAPY, 37 (9). pp. 4033-4042.

Collapse authors list.
Lampertico, Pietro, Mauss, Stefan, Persico, Marcello, Barclay, Stephen T, Marx, Steven, Lohmann, Kristina, Bondin, Mark, Zhang, ZhenZhen, Marra, Fiona ORCID: 0000-0003-1326-1149, Belperio, Pamela S et al (show 2 more authors) , Wedemeyer, Heiner and Flamm, Steven (2020) Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naive Patients with Compensated Cirrhosis (vol 37, pg 4033, 2020). ADVANCES IN THERAPY, 37 (11). pp. 4755-4756.

Collapse authors list.
Ferenci, Peter, Bourgeois, Stefan, Buggisch, Peter, Norris, Suzanne, Curescu, Manuela, Larrey, Dominique, Marra, Fiona ORCID: 0000-0003-1326-1149, Kleine, Henning, Dorr, Patrick, Charafeddine, Mariem et al (show 4 more authors) , Crown, Eric, Bondin, Mark, Back, David and Flisiak, Robert (2019) Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in hepatitis C virus genotype 1-and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries. JOURNAL OF VIRAL HEPATITIS, 26 (6). pp. 685-696.